We're thrilled to announce a major milestone in our journey to revolutionize respiratory care. Our team has been awarded an NSF SBIR Phase I grant to develop our respiratory dialysis therapy.
关于我们
X-COR Therapeutics is a medical device company creating the first commercially available CO2 removal device that uses ultra-low-blood flows for a cheaper, safer, and more accessible treatment for acute respiratory failure.
- 网站
-
https://xcortherapeutics.com
X-COR Therapeutics的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 2-10 人
- 总部
- Washington,District of Columbia
- 类型
- 私人持股
- 创立
- 2017
地点
-
主要
7144 13th Pl NW
US,District of Columbia,Washington,20012